Naive CD4+ T cells from patients at risk of MS onset and progression contained separate sets of differentially expressed genes including TOB1, which was downregulated and is known to suppress T-cell proliferation [64, 65]. The gene discussed is CD4; the disease is myeloid sarcoma.